CA2653300C - Vaccin polyvalent contre les infections a alphavirus de salmonide - Google Patents
Vaccin polyvalent contre les infections a alphavirus de salmonide Download PDFInfo
- Publication number
- CA2653300C CA2653300C CA2653300A CA2653300A CA2653300C CA 2653300 C CA2653300 C CA 2653300C CA 2653300 A CA2653300 A CA 2653300A CA 2653300 A CA2653300 A CA 2653300A CA 2653300 C CA2653300 C CA 2653300C
- Authority
- CA
- Canada
- Prior art keywords
- inactivated
- virus
- salmonid alphavirus
- cells
- spp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0233—Rickettsiales, e.g. Anaplasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/107—Vibrio
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/116—Polyvalent bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
- C07K14/1808—Alphaviruses or Group A arboviruses, e.g. sindbis, VEE, EEE, WEE, semliki forest virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36161—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La présente invention concerne une composition comprenant un arbovirus de salmonidé ou un matériau antigénique et/ou immunogénique dérivé combiné avec un ou plusieurs composants sélectionnés dans le groupe contenant les éléments suivants : une bactérie vivante, atténuée ou tuée, un virus autre que larbovirus de salmonidé, ledit virus étant de préférence atténué ou inactif, un champignon, un parasite et un matériau antigénique et/ou immunogénique dérivé de nimporte lequel de ces composants. Linvention concerne également une forme de dosage et un vaccin comprenant ladite composition, de même que lutilisation de la composition en médecine. Linvention concerne aussi une méthode de fabrication dune composition ou dun vaccin décrits ci-dessus et une méthode pour améliorer un vaccin polyvalent en y ajoutant un arbovirus de salmonidé atténué ou inactif.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3090088A CA3090088C (fr) | 2008-02-08 | 2009-02-06 | Vaccin polyvalent contre les infections a alphavirus de salmonide |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20080711 | 2008-02-08 | ||
NO20080711 | 2008-02-08 | ||
NO20080885 | 2008-02-20 | ||
NO20080885 | 2008-02-20 | ||
NO20090290 | 2009-01-20 | ||
NO20090290A NO333242B1 (no) | 2008-02-08 | 2009-01-20 | Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3090088A Division CA3090088C (fr) | 2008-02-08 | 2009-02-06 | Vaccin polyvalent contre les infections a alphavirus de salmonide |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2653300A1 CA2653300A1 (fr) | 2009-08-08 |
CA2653300C true CA2653300C (fr) | 2020-11-17 |
Family
ID=40469649
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3090088A Active CA3090088C (fr) | 2008-02-08 | 2009-02-06 | Vaccin polyvalent contre les infections a alphavirus de salmonide |
CA2653300A Active CA2653300C (fr) | 2008-02-08 | 2009-02-06 | Vaccin polyvalent contre les infections a alphavirus de salmonide |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3090088A Active CA3090088C (fr) | 2008-02-08 | 2009-02-06 | Vaccin polyvalent contre les infections a alphavirus de salmonide |
Country Status (4)
Country | Link |
---|---|
CA (2) | CA3090088C (fr) |
CL (1) | CL2009000287A1 (fr) |
GB (2) | GB2493662B (fr) |
NO (2) | NO333242B1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2688587B2 (fr) | 2011-03-25 | 2023-08-16 | Intervet International B.V. | Vaccin contre le alphavirus du saumon |
DK178233B1 (en) | 2012-09-17 | 2015-09-14 | Novartis Tiergesundheit Ag | Fiskevaccine |
NO344938B1 (en) * | 2018-12-13 | 2020-07-20 | Patogen As | Pancreas Disease Virus Markers |
BE1028701B1 (nl) * | 2020-10-13 | 2022-05-16 | Poulpharm Bvba | Werkwijze voor autovaccin productie en verkregen autovaccin |
CN112877399B (zh) * | 2021-01-20 | 2023-05-16 | 中国水产科学研究院黑龙江水产研究所 | 一种鲑鳟鱼致病菌药敏检测方法、药敏检测试剂盒及制备方法 |
WO2023034804A1 (fr) * | 2021-08-31 | 2023-03-09 | Zoetis Services Llc | Alphavirus atténué |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE251667T1 (de) * | 1994-10-18 | 2003-10-15 | Akzo Nobel Nv | Virus, welches die pankreas-krankheit bei fischen verursacht |
DE69936774D1 (de) * | 1998-05-08 | 2007-09-20 | Intervet Int Bv | Strukturproteine des virus, welches die pankreas-krankheit bei fischen verursacht, und ihre verwendungen |
AU2003229199A1 (en) * | 2002-05-31 | 2003-12-19 | Alpharma As | Liposome vaccine formulations for fin-fish |
DK179025B1 (da) * | 2005-09-16 | 2017-08-28 | Intervet Int Bv | Fiskevaccine |
CL2007001893A1 (es) * | 2006-06-29 | 2008-01-04 | Pharmaq As | Proceso para cultivar una bacteria del genero piscirickettsia en un medio cultivo libre de celulas huesped; proceso para obtener dichas bacterias; vacuna que comprende dichas bacterias; y alimento que comprende dicha vacuna para la prevencion de infecciones en peces con bacterias del genero piscirickettsia. |
-
2009
- 2009-01-20 NO NO20090290A patent/NO333242B1/no active Protection Beyond IP Right Term
- 2009-02-06 CL CL2009000287A patent/CL2009000287A1/es unknown
- 2009-02-06 GB GB1219654.9A patent/GB2493662B/en active Active
- 2009-02-06 CA CA3090088A patent/CA3090088C/fr active Active
- 2009-02-06 CA CA2653300A patent/CA2653300C/fr active Active
- 2009-02-06 GB GB0901913.4A patent/GB2457158B/en active Active
-
2015
- 2015-08-03 NO NO2015019C patent/NO2015019I1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA3090088C (fr) | 2023-01-31 |
GB2493662B (en) | 2013-04-17 |
CA2653300A1 (fr) | 2009-08-08 |
CA3090088A1 (fr) | 2009-08-08 |
GB2457158B (en) | 2013-04-03 |
GB2493662A (en) | 2013-02-13 |
GB201219654D0 (en) | 2012-12-12 |
NO2015019I1 (no) | 2015-08-10 |
GB0901913D0 (en) | 2009-03-11 |
NO20090290L (no) | 2009-08-10 |
CL2009000287A1 (es) | 2010-08-27 |
GB2457158A (en) | 2009-08-12 |
NO333242B1 (no) | 2013-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Urbano et al. | African swine fever control and prevention: an update on vaccine development | |
Offit et al. | Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection | |
CA2653300C (fr) | Vaccin polyvalent contre les infections a alphavirus de salmonide | |
JP3068204B2 (ja) | ブタの生殖・呼吸症候群(prrs)を惹起するウイルスの新規弱毒化株、それに由来するワクチンおよび診断キットならびにそれらの取得方法。 | |
US20110091490A1 (en) | Novel vaccine for dog | |
US20160122728A1 (en) | Ipn vaccine | |
JP2024009058A (ja) | ラッサワクチン | |
US8124100B2 (en) | Inactivated nodavirus vaccine | |
GB2452363A (en) | Fish virus which causes Cardiomyopathy Syndrome | |
KR100737434B1 (ko) | 돼지전염성위장염바이러스, 유행성설사바이러스 및로타바이러스의 혼합생백신 및 이를 이용한 백신접종방법 | |
JP7350864B2 (ja) | 異種スパイクタンパク質を有するh52 ibvワクチン | |
NO346254B1 (no) | Isolert salmonid alfavirus og anvendelse derav | |
JP4373916B2 (ja) | ニワトリ2型アストロウイルス | |
Rimstad | Vaccination against infectious pancreatic necrosis | |
US20050169939A1 (en) | Chicken anemia virus vaccine from cell line | |
NO20130080L (no) | Polyvalent vaksine mot salmonid alfavirusinfeksjoner | |
EP2640832B1 (fr) | Nouvel agent étiologique | |
WO2024003035A1 (fr) | Vaccins contre la piscirickettsiose (septicémie rickettsienne des salmonidés) | |
US10688176B2 (en) | Reoviridae vaccine | |
JP3040157B2 (ja) | イヌパルボウイルス(cpv)を含む弱毒イヌパルボウイルスワクチンとイヌ科動物におけるcpv感染予防 | |
WO2021123099A1 (fr) | Virus isa réassorti | |
AU2002332925A1 (en) | Chicken anemia virus vaccine from cell line |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20140205 |